Centiva Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Centiva Capital's BSX Position: Q2 2026 in Review
Centiva Capital increased its Boston Scientific (BSX) stake by 315% in Q2 2026, buying an estimated $6.19M and bringing the position to 150,288 shares worth $6.41M. The position accounts for 0.06% of the portfolio, ranked #232.
Centiva Capital first reported a position in BSX in Q3 2019 and has held it in 15 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Centiva Capital held 150,288 shares of Boston Scientific worth $6.41M as of Q2 2026.
- Centiva Capital bought 114,037 Boston Scientific shares in Q2 2026, an estimated $6.19M.
- Boston Scientific made up 0.06% of Centiva Capital's portfolio in Q2 2026, its #232 holding.
- Centiva Capital first reported a position in Boston Scientific in Q3 2019 and has held it in 15 quarters since.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.